Article

Familial pityriasis rubra pilaris: Report of a family and therapeutic response to etanercept

Department of Dermatology and Cutaneous Surgery, University of South Florida,Tampa, FL 33612, USA.
Journal of drugs in dermatology: JDD (Impact Factor: 1.32). 07/2010; 9(7):844-50.
Source: PubMed

ABSTRACT Pityriasis rubra pilaris (PRP) is an uncommon dermatosis of unknown etiology. The familial subtype is rare and usually presents as type V PRP. It is generally inherited in an autosomal dominant fashion with variable expression. Other forms of inheritance, such as autosomal recessive and X-linked, have also been reported. The use of etanercept in treating resistant forms of PRP is promising given reports of its success in a few cases. Herein, the authors report two cases of PRP arising in a mother and son and review the rare familial subtype of this disease. In addition, a successful therapeutic trial of etanercept was initiated in the mother based on case reports of its efficacy in other patients with PRP.

0 Followers
 · 
81 Views
 · 
0 Downloads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: La pitiriasis rubra pilaris es una dermatosis heterogénea rara en donde se asocian tres elementos semiológicos en grados diversos: una pápula córnea folicular, una queratodermia palmoplantar anaranjada y lesiones eritematoescamosas que pueden ser muy extensas con intervalos de piel sana. El origen de esta afección es confuso y en la mayoría de los casos existen factores desencadenantes traumáticos o infecciosos, que probablemente actúan en un contexto de predisposición. En otros casos se observa una asociación a desórdenes inmunológicos o bien, en casos familiares, alteraciones genéticas de la queratinización cercanos a la ictiosis. Ante esta gran variabilidad semiológica se han propuesto varias clasificaciones basadas en criterios clínicos y evolutivos. La evolución varía en función de las formas clínicas. El enfoque terapéutico no está bien codificado y no existen ensayos terapéuticos disponibles, debido a la rareza de la enfermedad. Los mejores resultados parecen obtenerse con retinoides orales, y en segunda línea se hallan el metotrexato y la ciclosporina. Los nuevos inhibidores del factor de necrosis tumoral α podrían presentar gran interés en el futuro.
    01/2006; 40(3):1–9. DOI:10.1016/S1761-2896(06)47743-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pityriasis rubra pilaris (PRP) includes a spectrum of rare chronic inflammatory disorders with papulosquamous eruptions of unknown cause. Different etiologies have been proposed such as vitamin A metabolism dysfunction, association with autoimmune disorders, infection or malignancies. However, PRP seems to be a polygenic skin disorder. Classical systemic treatment is empirical and includes retinoids and methotrexate; however, only few series on treatments exist. Recently there has been an increasing number of reports documenting that new biologicals and in particular TNF-α blockers are safe and effective.
    Dermatology 04/2012; 224(2):120-5. DOI:10.1159/000337546 · 1.69 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pityriasis rubra pilaris (PRP) is a papulosquamous disorder phenotypically related to psoriasis. The disease has been occasionally shown to be inherited in an autosomal-dominant fashion. To identify the genetic cause of familial PRP, we ascertained four unrelated families affected by autosomal-dominant PRP. We initially mapped PRP to 17q25.3, a region overlapping with psoriasis susceptibility locus 2 (PSORS2 [MIM 602723]). Using a combination of linkage analysis followed by targeted whole-exome sequencing and candidate-gene screening, we identified three different heterozygous mutations in CARD14, which encodes caspase recruitment domain family, member 14. CARD14 was found to be specifically expressed in the skin. CARD14 is a known activator of nuclear factor kappa B signaling, which has been implicated in inflammatory disorders. Accordingly, CARD14 levels were increased, and p65 was found to be activated in the skin of PRP-affected individuals. The present data demonstrate that autosomal-dominant PRP is allelic to familial psoriasis, which was recently shown to also be caused by mutations in CARD14.
    The American Journal of Human Genetics 06/2012; 91(1):163-70. DOI:10.1016/j.ajhg.2012.05.010 · 10.99 Impact Factor
Show more